Top 30 Medical Device Manufacturers 2026

This report forms part of The Economy Rankings Healthcare Ranking series, which evaluates hospitals, medical institutions, pharmaceutical organizations, medical technology companies, diagnostics providers, laboratories, precision medicine platforms, pharmaceutical services providers, medical technology firms, and healthcare systems across global healthcare markets.

Medical device manufacturers occupy a foundational position within modern healthcare by developing, producing, and commercializing the technologies used in diagnosis, monitoring, surgery, intervention, rehabilitation, chronic disease management, and hospital care. Their products include implantable devices, surgical instruments, imaging systems, patient monitoring equipment, diagnostic platforms, cardiovascular devices, orthopedic implants, diabetes technologies, ophthalmology systems, robotic surgery platforms, wound care products, and hospital infrastructure technologies.

Unlike pharmaceutical companies, medical device manufacturers compete through engineering, clinical usability, regulatory execution, manufacturing quality, physician adoption, hospital procurement, procedural training, service networks, and installed technology platforms. Their institutional relevance is determined not only by revenue scale, but also by product reliability, innovation pipeline, global distribution, hospital integration, physician trust, and ability to support evolving models of care.

The medical device sector continues to benefit from aging populations, rising chronic disease burdens, elective procedure recovery, minimally invasive surgery, structural heart innovation, robotic surgery, diabetes technology, advanced imaging, and digital integration. At the same time, the sector faces regulatory scrutiny, pricing pressure, supply-chain risk, hospital capital constraints, cybersecurity requirements, and competition from AI-enabled diagnostics and digital health platforms.

This ranking identifies medical device manufacturers whose platforms demonstrate sustained relevance across clinical impact, product breadth, innovation, global reach, manufacturing capability, and long-term healthcare infrastructure importance. Rather than focusing only on one-year revenue, the objective is to recognize companies whose device businesses remain structurally important within global healthcare.

Market Overview

The global medical device industry remains one of the largest and most strategically important segments of healthcare technology. The sector is led by multinational companies with broad portfolios across cardiovascular care, surgery, orthopedics, diagnostics, imaging, diabetes management, patient monitoring, and hospital technologies.

Industry rankings continue to identify Medtronic, Johnson & Johnson MedTech, Abbott, Siemens Healthineers, Stryker, Becton Dickinson, GE HealthCare, Boston Scientific, and Intuitive Surgical among the largest and most influential medical device companies by revenue and market presence. Medical Design & Outsourcing’s 2025 Medtech Big 100 ranked the world’s largest medical device companies by revenue, while other sector reports similarly identify Medtronic, Johnson & Johnson MedTech, Abbott, Siemens Healthineers, Stryker, BD, GE HealthCare, Boston Scientific, and Intuitive Surgical among the leading global medtech groups.

The sector is becoming more specialized and technology-driven. Cardiovascular devices remain a major growth category, supported by electrophysiology, structural heart, transcatheter valve interventions, cardiac rhythm management, coronary intervention, peripheral vascular treatment, and heart failure management. Surgical technologies continue to evolve through robotic surgery, advanced energy devices, minimally invasive instruments, endoscopy, surgical navigation, and procedure-specific platforms.

Orthopedics remains an important global device category, driven by joint replacement, trauma, spine, sports medicine, extremities, robotic-assisted orthopedic surgery, and aging-related musculoskeletal demand. Stryker, Zimmer Biomet, Smith+Nephew, DePuy Synthes, and Medtronic’s spine business remain key participants in this segment.

Diagnostics and imaging are increasingly integrated with broader device platforms. Siemens Healthineers, GE HealthCare, Philips, Canon Medical, and Fujifilm remain important in imaging and hospital infrastructure, while Abbott, Roche Diagnostics, BD, Danaher, and Thermo Fisher maintain major roles in diagnostic instruments and clinical technology systems.

The industry also remains active in portfolio reshaping. Medtronic announced plans to separate its diabetes business, reflecting a strategic effort to sharpen focus across cardiovascular, neuroscience, surgical, and diabetes-related technologies. Johnson & Johnson’s acquisition of Shockwave Medical strengthened its cardiovascular intervention platform, showing continued appetite for device M&A in high-growth clinical categories.

Industry Trend — 2026

The medical device industry in 2026 is shaped by five major trends: minimally invasive intervention, robotic and digitally enabled surgery, chronic disease technology, imaging and diagnostics integration, and portfolio specialization.

First, minimally invasive cardiovascular procedures remain a major growth driver. Structural heart disease, electrophysiology, peripheral vascular disease, coronary intervention, and heart failure management continue to attract device innovation and capital investment. Companies such as Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, Johnson & Johnson MedTech, and Terumo remain highly relevant in this area.

Second, robotic and digitally enabled surgery continues to expand. Intuitive Surgical remains the benchmark company in robotic surgery, while Medtronic, Johnson & Johnson, Stryker, Zimmer Biomet, Smith+Nephew, and others continue to invest in robotic, navigated, or digitally assisted procedural technologies. Hospitals increasingly evaluate surgical platforms not only by device performance but also by training, data integration, procedure volume, and operating room efficiency.

Third, chronic disease device technology is becoming more important. Diabetes technologies, continuous glucose monitoring, insulin delivery systems, connected monitoring devices, cardiac rhythm technologies, sleep and respiratory devices, and home-based monitoring are shifting care from episodic hospital treatment toward continuous disease management. Abbott’s medical device sales remained a key growth driver in 2025, with investor reporting highlighting strong device performance and investment in U.S. manufacturing and R&D facilities.

Fourth, imaging and diagnostics are becoming more platform-based. Imaging companies increasingly combine scanners, software, AI workflows, service contracts, data systems, and clinical decision support. Diagnostic device companies similarly compete through installed instruments, consumables, workflow integration, automation, and data connectivity.

Fifth, medtech companies are becoming more selective in portfolio management. Large firms are divesting slower-growth assets, acquiring specialist platforms, and investing in categories with durable procedure growth, recurring revenue, and strong clinical differentiation. The strongest manufacturers are those able to combine engineering innovation with regulatory execution, hospital access, physician training, and global supply reliability.

Methodology — Core Eligibility Criteria

To ensure structural consistency within the category, organizations considered for this ranking were evaluated based on the following eligibility conditions:

• Operates primarily as a medical device manufacturer, medical technology company, diagnostic device manufacturer, imaging equipment provider, surgical technology company, or hospital technology manufacturer
• Provides products such as implantable devices, surgical instruments, imaging systems, diagnostic instruments, patient monitoring systems, orthopedic implants, cardiovascular devices, diabetes technologies, robotic surgery platforms, or hospital equipment
• Maintains meaningful institutional scale through global commercial operations, regulatory approvals, manufacturing capacity, hospital relationships, physician adoption, or installed device platforms
• Demonstrates relevance in acute care, surgery, diagnostics, chronic disease management, imaging, interventional medicine, rehabilitation, or hospital infrastructure
• Represents a specific license-targetable operating organization, rather than a broad platform category, trade association, informal network, or industry group

Pure pharmaceutical companies, software-only digital health vendors without meaningful device manufacturing, contract manufacturers without branded device platforms, distributors without meaningful product ownership, and early-stage device startups without sufficient commercial scale were generally excluded.

Methodology — Ranking Factors

Organizations included in the ranking were evaluated using a combination of qualitative and structural considerations rather than short-term market capitalization alone. Key factors considered include:

• Scale and durability of medical device revenue
• Breadth and quality of device portfolio
• Leadership in high-impact categories such as cardiovascular care, surgery, orthopedics, diagnostics, imaging, diabetes, and patient monitoring
• Product innovation, regulatory execution, and clinical evidence
• Global manufacturing, supply-chain resilience, and service infrastructure
• Physician adoption, hospital procurement relevance, and installed base strength
• Digital integration, robotics, AI-enabled workflow, and connected device capability
• Institutional stability, brand reputation, and long-term platform relevance

The objective of the ranking is to identify medical device manufacturers whose platforms maintain sustained relevance within the global healthcare ecosystem.

The Healthcare Ranking Top 30 Medical Device Manufacturers 2026 ranking evaluates medical technology companies based on device scale, clinical relevance, innovation capability, global reach, manufacturing strength, and long-term institutional resilience.

The ranking universe consisted of approximately 150 medical device and medical technology manufacturers globally, from which 30 organizations were selected for inclusion.

Tier classifications reflect relative institutional positioning within the medical device manufacturer segment and do not represent clinical recommendations, investment recommendations, procurement advice, or endorsement of any specific medical device.

---

Company Profiles and Further Reference

Organization names appearing in this ranking are linked to their corresponding profiles in The Economy Wiki for companies. These profiles provide additional background on each institution, including its principal activities, clinical or commercial focus, market positioning, leadership, corporate information, related rankings, and analysis across The Economy Network.

The Economy Wiki profiles are maintained as editorial reference pages and may be updated as new public information becomes available. A linked profile does not affect ranking eligibility or tier classification.

---

Tier I — Leading Medical Device Manufacturers

Medtronic

• Headquarters: Dublin, Ireland / Operational headquarters: Minneapolis, United States
• Founded: 1949

Medtronic remains one of the most important medical device manufacturers globally and one of the broadest platforms in the medtech industry. The company operates across cardiovascular devices, cardiac rhythm management, structural heart, neuromodulation, spine, surgical technologies, patient monitoring, respiratory care, and diabetes technology.

Medtronic’s strength lies in portfolio breadth and installed clinical presence. Its devices are used across many of the most important procedural and chronic disease areas in healthcare, including heart disease, neurological disorders, diabetes, spine surgery, general surgery, and hospital monitoring. This breadth gives Medtronic relevance across hospitals, ambulatory surgery centers, specialist physician practices, and chronic disease care pathways.

The company continues to reshape its portfolio. Its announced plan to separate the diabetes business reflects a broader effort to focus capital and management attention on higher-margin cardiovascular, neuroscience, and surgical technology businesses while allowing the diabetes platform to operate with greater strategic focus.

Medtronic’s global scale, diversified device portfolio, cardiovascular and neuroscience leadership, manufacturing infrastructure, and long-standing physician relationships support its position as a Tier I medical device manufacturer in 2026.

Johnson & Johnson MedTech

• Headquarters: New Brunswick, United States
• Founded: Johnson & Johnson founded 1886

Johnson & Johnson MedTech is one of the most important medical device platforms globally, with major businesses across surgery, orthopedics, electrophysiology, cardiovascular intervention, and vision care. Following Johnson & Johnson’s separation of its consumer health business, the company’s healthcare identity has become more concentrated around innovative medicine and medical technology.

J&J MedTech’s strength lies in its combination of procedural breadth, physician relationships, and global commercial reach. Its Ethicon surgical portfolio, DePuy Synthes orthopedics platform, Biosense Webster electrophysiology business, Abiomed heart recovery platform, and cardiovascular expansion through Shockwave Medical give it relevance across several high-value device categories.

The Shockwave acquisition strengthened J&J’s position in interventional cardiovascular care by adding intravascular lithotripsy technology for calcified arterial lesions. The transaction followed earlier cardiovascular investment through Abiomed, showing the company’s strategic interest in high-growth interventional device categories.

Johnson & Johnson MedTech’s surgical depth, orthopedic footprint, cardiovascular expansion, electrophysiology leadership, and global device infrastructure support its Tier I position.

Abbott

• Headquarters: Abbott Park, United States
• Founded: 1888

Abbott is one of the most important global medical technology companies, with major businesses across cardiovascular devices, diabetes care, diagnostics, neuromodulation, structural heart, electrophysiology, nutrition, and established pharmaceuticals. Within medical devices, Abbott is especially relevant in continuous glucose monitoring, structural heart, rhythm management, vascular intervention, and diagnostic technologies.

Abbott’s strength lies in the combination of chronic disease technology and interventional platforms. Its FreeStyle Libre continuous glucose monitoring franchise has become one of the most important diabetes technologies globally, while its cardiovascular businesses cover electrophysiology, heart failure, structural heart, vascular devices, and cardiac rhythm management.

The company’s 2025 performance continued to show device strength. Public reporting noted that medical device sales were a key driver for Abbott, increasing strongly in early 2025, and the company also announced investment in new U.S. manufacturing and R&D facilities.

Abbott’s diabetes technology leadership, cardiovascular portfolio, diagnostics infrastructure, global manufacturing base, and chronic disease relevance support its position as a Tier I medical device manufacturer.

Siemens Healthineers

• Headquarters: Erlangen, Germany
• Founded: 2017 as separately listed company

Siemens Healthineers is one of the world’s leading medical technology companies, with major strength in diagnostic imaging, laboratory diagnostics, radiation oncology, digital health infrastructure, and clinical workflow technologies. The company’s portfolio includes MRI, CT, X-ray, ultrasound, molecular imaging, angiography, laboratory diagnostics, point-of-care testing, and cancer treatment technologies through Varian.

Siemens Healthineers’ strength lies in hospital infrastructure and diagnostic depth. Imaging and diagnostics are central to modern healthcare, and Siemens Healthineers is one of the core vendors supporting radiology departments, cancer centers, laboratories, emergency medicine, cardiology, and surgical planning.

The acquisition of Varian expanded the company’s relevance in radiation oncology and cancer care, linking imaging, treatment planning, and radiotherapy. This makes Siemens Healthineers especially important in integrated oncology infrastructure.

Siemens Healthineers’ imaging leadership, diagnostics platform, oncology technology, global installed base, and hospital system integration support its Tier I position.

Stryker

• Headquarters: Kalamazoo, United States
• Founded: 1941

Stryker is one of the leading global medical device manufacturers, with major positions in orthopedics, surgical equipment, neurotechnology, spine, trauma, joint replacement, sports medicine, and robotic-assisted surgery. The company has built a reputation for disciplined execution, strong sales culture, and consistent expansion across procedural device categories.

Stryker’s strength lies in musculoskeletal and surgical technology. Its orthopedic implant portfolio, Mako robotic-assisted surgery platform, trauma devices, spine products, neurovascular technologies, and surgical equipment give it broad relevance across operating rooms, orthopedic hospitals, ambulatory surgery centers, and trauma systems.

The company is especially important because orthopedics remains one of the largest device categories globally, driven by aging populations, joint replacement demand, sports injuries, trauma, and mobility-related care. Stryker’s robotic orthopedic platform also positions it well in the shift toward digitally assisted surgery.

Stryker’s orthopedic leadership, surgical technology breadth, robotic-assisted surgery platform, neurotechnology business, and strong commercial execution support its Tier I position.

---

Tier II — Established Medical Device Manufacturers

(Alphabetical order)

Becton Dickinson

• Headquarters: Franklin Lakes, United States
• Founded: 1897

Becton Dickinson, commonly known as BD, is one of the most important global medical technology manufacturers in medication delivery, diagnostic systems, biosciences, infection prevention, and hospital infrastructure. Its products include needles, syringes, infusion systems, medication management technologies, specimen collection devices, diagnostic instruments, and flow cytometry platforms.

BD’s strength lies in its role as essential healthcare infrastructure. Many BD products are not glamorous high-ticket implants, but they are embedded in daily clinical workflows across hospitals, laboratories, pharmacies, outpatient centers, and public health systems.

The company is particularly relevant in medication safety, laboratory automation, specimen collection, microbiology, and biosciences research. Its installed base and consumable-driven model provide recurring relevance within healthcare systems.

BD’s global reach, hospital penetration, diagnostic systems, medication management platform, and manufacturing scale support its inclusion among established medical device manufacturers.

Boston Scientific

• Headquarters: Marlborough, United States
• Founded: 1979

Boston Scientific is one of the most important specialist medical device companies globally, with strong positions in cardiovascular intervention, electrophysiology, endoscopy, peripheral interventions, urology, pelvic health, and neuromodulation. The company has become particularly relevant in high-growth procedural categories.

Boston Scientific’s strength lies in interventional medicine. Its products are used by cardiologists, electrophysiologists, gastroenterologists, urologists, vascular specialists, pain specialists, and surgeons across minimally invasive procedures. This gives the company strong exposure to procedural growth and specialist physician adoption.

The company has continued to expand through internal innovation and acquisition. Its cardiovascular and electrophysiology businesses are especially important as arrhythmia treatment, left atrial appendage closure, coronary intervention, and structural heart-adjacent procedures continue to grow.

Boston Scientific’s specialist focus, cardiovascular strength, electrophysiology growth, endoscopy presence, and global procedural device platform support its position among established manufacturers.

Canon Medical Systems

• Headquarters: Otawara, Japan
• Founded: 1948

Canon Medical Systems is a major global diagnostic imaging manufacturer with products across CT, MRI, ultrasound, X-ray, angiography, and healthcare IT. As part of Canon Group, the company brings imaging engineering, global service infrastructure, and long-standing radiology relationships.

Canon Medical’s strength lies in diagnostic imaging technology. Imaging systems are core hospital infrastructure and support emergency medicine, oncology, cardiology, neurology, orthopedics, surgery, and preventive care. Canon’s CT and ultrasound platforms are especially relevant in competitive imaging markets.

The company’s Japanese engineering base and global sales network make it an important alternative to Siemens Healthineers, GE HealthCare, Philips, Fujifilm, and other imaging technology providers.

Canon Medical Systems’ imaging portfolio, international footprint, hospital relevance, and engineering heritage support its inclusion among established medical device manufacturers.

Danaher

• Headquarters: Washington, D.C., United States
• Founded: 1984

Danaher is a major healthcare technology and life sciences company with strong relevance in diagnostics, life sciences instruments, laboratory systems, and bioprocessing technologies. Its operating companies include platforms involved in clinical diagnostics, pathology, genomics, molecular testing, life sciences research, and biomanufacturing support.

Danaher’s strength lies in instruments and workflow platforms rather than traditional implantable devices. Its diagnostic and life sciences technologies are embedded in laboratories, research institutions, biopharmaceutical manufacturing, and clinical testing environments.

The company’s business system, acquisition discipline, and portfolio of specialized technology companies give it a distinctive position in healthcare infrastructure. While not a conventional surgical-device company, Danaher remains highly relevant within medical technology because of its diagnostic instruments and laboratory platforms.

Danaher’s diagnostics footprint, life sciences technology base, and laboratory infrastructure relevance support its inclusion among established medical device manufacturers.

Edwards Lifesciences

• Headquarters: Irvine, United States
• Founded: 1958

Edwards Lifesciences is one of the leading cardiovascular device manufacturers globally, with a defining position in structural heart disease and transcatheter heart valve therapy. The company is especially associated with transcatheter aortic valve replacement and related heart valve technologies.

Edwards’ strength lies in focused leadership. Rather than operating as a broad device conglomerate, Edwards concentrates on high-value cardiovascular categories requiring strong clinical evidence, physician training, regulatory execution, and procedural ecosystem development.

Structural heart disease remains one of the most important growth areas in medtech because aging populations increase the prevalence of valvular heart disease, and minimally invasive treatment options continue to expand. Edwards is a central company in this transformation.

Edwards Lifesciences’ heart valve leadership, structural heart specialization, clinical evidence base, and physician adoption support its position among established manufacturers.

Fujifilm Healthcare

• Headquarters: Tokyo, Japan
• Founded: Fujifilm founded 1934

Fujifilm Healthcare is a major global medical technology platform with strong positions in diagnostic imaging, endoscopy, ultrasound, digital radiography, healthcare IT, and medical systems. The company has expanded its healthcare business significantly over the past decade through organic development and acquisitions.

Fujifilm’s strength lies in imaging and visual technology. Its portfolio supports radiology, endoscopy, surgical visualization, point-of-care imaging, and digital health workflows. The company’s expertise in imaging science provides a strong foundation for medical technology applications.

The company is also strategically relevant because Fujifilm Group has invested heavily in life sciences, biomanufacturing, and healthcare infrastructure. This broader healthcare commitment strengthens Fujifilm’s positioning beyond traditional imaging equipment.

Fujifilm Healthcare’s imaging heritage, endoscopy platform, global healthcare investment, and diagnostic technology relevance support its inclusion among established medical device manufacturers.

GE HealthCare

• Headquarters: Chicago, United States
• Founded: 2023 as independent company

GE HealthCare is one of the world’s leading medical technology companies, with major positions in diagnostic imaging, ultrasound, patient monitoring, anesthesia care, maternal-infant care, pharmaceutical diagnostics, and healthcare digital solutions. Its independence from General Electric has given the company a clearer medtech identity.

GE HealthCare’s strength lies in imaging and monitoring infrastructure. Its MRI, CT, ultrasound, X-ray, molecular imaging, and monitoring products are widely used across hospitals, clinics, emergency departments, and specialty care settings. The company also has meaningful relevance in contrast agents and pharmaceutical diagnostics.

The company’s installed base gives it strong recurring service, software, and lifecycle opportunities. As hospitals invest in workflow efficiency, AI integration, and equipment modernization, GE HealthCare remains one of the most important vendors in global healthcare infrastructure.

GE HealthCare’s imaging scale, patient monitoring platform, installed base, and independent medtech focus support its position among established medical device manufacturers.

Intuitive Surgical

• Headquarters: Sunnyvale, United States
• Founded: 1995

Intuitive Surgical is the leading company in robotic-assisted surgery and one of the most influential medical device manufacturers in modern procedural medicine. Its da Vinci surgical system has become a benchmark platform in minimally invasive robotic surgery across urology, gynecology, general surgery, thoracic surgery, and other specialties.

Intuitive’s strength lies in platform economics and procedural ecosystem development. The company does not simply sell capital equipment; it supports a system of instruments, accessories, surgeon training, procedure adoption, service contracts, and installed-base expansion.

Robotic surgery remains one of the most important strategic areas in medtech. Hospitals evaluate robotic platforms based on surgical precision, patient outcomes, surgeon adoption, operating room utilization, and procedure growth. Intuitive remains the dominant reference point in this category despite increasing competition.

Intuitive Surgical’s robotic surgery leadership, installed base, recurring instrument revenue, clinical training infrastructure, and procedure expansion support its inclusion among established medical device manufacturers.

Philips HealthTech

• Headquarters: Amsterdam, Netherlands
• Founded: Philips founded 1891

Philips HealthTech remains a major global medical technology company with businesses across diagnostic imaging, image-guided therapy, patient monitoring, ultrasound, respiratory care, sleep care, and connected healthcare. The company is particularly relevant in hospital systems, imaging suites, intensive care, and image-guided intervention.

Philips’ strength lies in connected care and image-guided therapy. Its products support patient monitoring, cardiovascular intervention, radiology, ultrasound, and hospital workflow integration. These areas align with the industry’s movement toward integrated digital and procedural platforms.

The company has faced significant reputational and regulatory pressure related to respiratory device recalls, which remains an important consideration for governance and quality evaluation. However, Philips continues to operate one of the major global medtech platforms.

Philips HealthTech’s imaging, monitoring, image-guided therapy, and connected care capabilities support its inclusion among established manufacturers, while quality and recall governance remain important monitoring factors.

Zimmer Biomet

• Headquarters: Warsaw, United States
• Founded: 1927 / Zimmer Biomet formed 2015

Zimmer Biomet is one of the leading orthopedic device manufacturers globally, with major positions in joint replacement, trauma, sports medicine, extremities, surgical robotics, and musculoskeletal care. The company is especially relevant in hip and knee implants, where long-term demographic demand remains strong.

Zimmer Biomet’s strength lies in orthopedic specialization. Joint replacement and musculoskeletal surgery require strong surgeon relationships, implant reliability, instrumentation systems, revision support, clinical data, and procedure-specific training.

The company has invested in digital and robotic technologies to support orthopedic surgery, reflecting the sector’s shift toward procedural planning, intraoperative guidance, and data-enabled musculoskeletal care.

Zimmer Biomet’s orthopedic scale, implant portfolio, surgeon relationships, and musculoskeletal technology platform support its position among established medical device manufacturers.

---

Tier III — Specialist Medical Device Manufacturers

(Alphabetical order)

Alcon

• Headquarters: Geneva, Switzerland
• Founded: 1945

Alcon is a leading ophthalmic medical device and vision care company, with major businesses in surgical eye care and contact lenses. Its products include cataract surgery systems, intraocular lenses, surgical equipment, ophthalmic consumables, contact lenses, and eye care products.

Alcon’s strength lies in focused ophthalmology leadership. Eye care is a large and growing segment supported by aging populations, cataract surgery demand, refractive correction, retinal disease, and consumer vision care.

The company’s surgical and vision care portfolio gives it strong relevance among ophthalmologists, optometrists, ambulatory surgery centers, and eye hospitals. Its focused specialty platform supports its inclusion among specialist medical device manufacturers.

Align Technology

• Core focus: digital orthodontics, clear aligners and intraoral scanning

Align Technology is an established healthcare institution whose principal relevance to this ranking lies in digital orthodontics, clear aligners and intraoral scanning. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Align Technology contributes a credible combination of these characteristics.

Align Technology is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

B. Braun

• Headquarters: Melsungen, Germany
• Founded: 1839

B. Braun is a major privately held medical technology manufacturer with broad relevance in infusion therapy, surgical instruments, vascular access, hospital supplies, renal care, and healthcare consumables. The company operates globally and has a long history in medical technology manufacturing.

B. Braun’s strength lies in essential hospital products and supply reliability. Its devices and consumables are used across inpatient care, surgery, anesthesia, infusion therapy, dialysis, and outpatient treatment.

The company’s privately held structure and German manufacturing heritage give it a distinctive institutional profile. Its broad hospital supply platform supports its inclusion among specialist medical device manufacturers.

Baxter

• Headquarters: Deerfield, United States
• Founded: 1931

Baxter is a major medical technology company focused on hospital products, infusion systems, renal care, surgical care, acute therapies, nutrition, and patient support technologies. Its devices and products are embedded in hospital, dialysis, intensive care, and home care workflows.

Baxter’s strength lies in essential care infrastructure. Infusion pumps, renal technologies, hospital products, and acute therapies may not always be high-growth categories, but they are critical to patient care delivery and hospital operations.

The company has undergone portfolio changes and debt-related pressure following the Hillrom acquisition, but it remains a significant global device manufacturer with broad hospital relationships.

Baxter’s hospital infrastructure role, renal care platform, infusion technologies, and global installed base support its inclusion among specialist manufacturers.

Cook Medical

• Core focus: minimally invasive medical devices across multiple specialties

Cook Medical is an established healthcare institution whose principal relevance to this ranking lies in minimally invasive medical devices across multiple specialties. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Cook Medical contributes a credible combination of these characteristics.

Cook Medical is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Dexcom

• Core focus: continuous glucose monitoring systems and diabetes technology

Dexcom is an established healthcare institution whose principal relevance to this ranking lies in continuous glucose monitoring systems and diabetes technology. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Dexcom contributes a credible combination of these characteristics.

Dexcom is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Dräger

• Core focus: critical care, anesthesia, ventilation and hospital safety equipment

Dräger is an established healthcare institution whose principal relevance to this ranking lies in critical care, anesthesia, ventilation and hospital safety equipment. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Dräger contributes a credible combination of these characteristics.

Dräger is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Fresenius Medical Care

• Core focus: dialysis equipment, consumables and renal-care technology

Fresenius Medical Care is an established healthcare institution whose principal relevance to this ranking lies in dialysis equipment, consumables and renal-care technology. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Fresenius Medical Care contributes a credible combination of these characteristics.

Fresenius Medical Care is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Getinge

• Core focus: surgical, intensive-care and sterile-processing equipment

Getinge is an established healthcare institution whose principal relevance to this ranking lies in surgical, intensive-care and sterile-processing equipment. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Getinge contributes a credible combination of these characteristics.

Getinge is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Hologic

• Core focus: women’s health diagnostics, imaging and surgical products

Hologic is an established healthcare institution whose principal relevance to this ranking lies in women’s health diagnostics, imaging and surgical products. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Hologic contributes a credible combination of these characteristics.

Hologic is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Insulet

• Core focus: tubeless insulin delivery and diabetes-management devices

Insulet is an established healthcare institution whose principal relevance to this ranking lies in tubeless insulin delivery and diabetes-management devices. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Insulet contributes a credible combination of these characteristics.

Insulet is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Olympus

• Core focus: endoscopy, minimally invasive therapy and medical visualization

Olympus is an established healthcare institution whose principal relevance to this ranking lies in endoscopy, minimally invasive therapy and medical visualization. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Olympus contributes a credible combination of these characteristics.

Olympus is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

ResMed

• Core focus: sleep, respiratory and connected home-care devices

ResMed is an established healthcare institution whose principal relevance to this ranking lies in sleep, respiratory and connected home-care devices. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in medical Device Manufacturers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. ResMed contributes a credible combination of these characteristics.

ResMed is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Smith+Nephew

• Headquarters: London, United Kingdom
• Founded: 1856

Smith+Nephew is a major medical device manufacturer focused on orthopedics, sports medicine, advanced wound management, and surgical technologies. The company has a strong international presence and a long history in musculoskeletal care.

Smith+Nephew’s strength lies in focused procedural categories. Its sports medicine and orthopedic platforms serve surgeons managing joint repair, arthroscopy, reconstruction, trauma, and mobility-related conditions. Its advanced wound management business provides additional relevance in chronic care, surgical recovery, and tissue healing.

The company is smaller than Stryker and Zimmer Biomet but remains a meaningful global orthopedic and wound care device manufacturer.

Smith+Nephew’s musculoskeletal focus, wound care platform, surgical technologies, and global footprint support its Tier III inclusion.

Terumo

• Headquarters: Tokyo, Japan
• Founded: 1921

Terumo is a major Japanese medical device manufacturer with strong positions in cardiovascular intervention, vascular access, blood management, injection systems, infusion technologies, and hospital devices. The company has a significant global presence and is especially relevant in interventional medicine and blood-related technologies.

Terumo’s strength lies in cardiovascular and vascular procedure devices. Its products support interventional cardiology, peripheral intervention, neurovascular care, endovascular procedures, and hospital-based patient care.

The company’s Japanese manufacturing base, global distribution, and focused device portfolio make it an important specialist manufacturer within the global medtech sector.

Terumo’s cardiovascular device expertise, blood management platform, global reach, and interventional technology relevance support its inclusion among specialist medical device manufacturers.

---

Remarks

Medical device manufacturers continue to serve as essential infrastructure for modern healthcare. Their products enable diagnosis, surgery, intervention, monitoring, chronic disease management, rehabilitation, and hospital operations across nearly every clinical specialty.

The organizations recognized in this ranking represent companies whose device platforms maintain sustained relevance across cardiovascular care, surgery, orthopedics, diagnostics, imaging, diabetes technology, patient monitoring, ophthalmology, hospital systems, and digitally enabled care. Tier classification reflects relative institutional positioning within the medical device manufacturer sector rather than direct clinical quality rankings.

Tier classification reflects relative device scale, clinical impact, portfolio breadth, innovation capability, regulatory execution, manufacturing quality, hospital relevance, physician adoption, and long-term platform resilience. The ranking does not constitute a medical recommendation, patient referral guidance, procurement recommendation, investment recommendation, or endorsement of any specific device.

---

Recognition

Inclusion in the Top 30 Medical Device Manufacturers 2026 ranking is an editorial determination of The Economy Rankings and is independent of licensing, advertising, sponsorship, or other commercial participation.

Ranked organizations may factually refer to their inclusion in the ranking in their own communications. When describing the result, institutions should accurately reflect the tier structure and methodology used in the published ranking.

How the ranking should be interpreted

• Tier I represents the Top 5 institutions, and the published order within Tier I reflects the ranking order.
• Tier II represents institutions ranked within the Top 15, following Tier I. Institutions within Tier II are displayed alphabetically; their displayed order should therefore not be interpreted as an individual numerical ranking.
• Tier III represents institutions ranked within the Top 30, following Tiers I and II. Institutions within Tier III are also displayed alphabetically, and their displayed order should not be interpreted as an individual numerical ranking.
• An institution’s tier, rather than its alphabetical position within Tier II or Tier III, should therefore be used when describing its standing.

Referencing the ranking

Depending on the institution’s published tier, appropriate factual descriptions may include:

• Tier I: “Ranked Tier I” or “Ranked among the Top 5”
• Tier II: “Ranked Tier II” or “Ranked among the Top 15”
• Tier III: “Ranked Tier III” or “Ranked among the Top 30”

Organizations should not describe an alphabetical position within Tier II or Tier III as a specific numerical rank.

Use of The Economy Rankings recognition materials

Editorial inclusion in a ranking does NOT by itself grant permission to use The Economy Rankings badges, seals, logos, official recognition graphics, licensed quotations, or other proprietary recognition materials.

Organizations wishing to use official The Economy Rankings recognition materials in corporate websites, marketing materials, investor communications, patient or professional communications, presentations, social media, press releases, or other external communications should refer to the applicable licensing terms and usage policies:

• The Economy Rankings License Structure — available licence levels and permitted recognition uses
  Rankings License Structure | The Economy
• The Economy Rankings License Policy — licensing conditions governing use of The Economy Rankings recognition, marks, and related materials
  The Economy Rankings License Policy | The Economy
• Recognition Use Guide — guidance on permitted wording, presentation, attribution, and use of ranking recognition
  Recognition Use Guide | The Economy

Ranking inclusion remains editorially independent regardless of whether an organization purchases or holds a recognition-materials licence.

Licensing inquiries:
[email protected]